No evidence of increased oxidative degradation of urate to allantoin in the CSF and serum of patients with multiple sclerosis.
Kastenbauer
Stefan
S
Kieseier
Bernd C
BC
Becker
Bernhard F
BF
D000328:Adult; D000481:Allantoin / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood* / Q000134:cerebrospinal fluid*; D018384:Oxidative Stress / Q000502:physiology*; D014527:Uric Acid / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*
D014527:Uric Acid; D000481:Allantoin
J Neurol. 2001 Feb;248(2):121-6
11284129
Neurol Sci. 2002 Oct;23(4):183-8
12536287
Mult Scler. 2001 Jun;7(3):165-6
11475439
Eur J Neurol. 2002 May;9(3):221-6
11985629
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):675-80
9435251
J Neurol. 1999 Jul;246(7):533-9
10463352
Neurology. 2002 Jan 22;58(2):186-91
11805243
J Neurol. 2004 Mar;251(3):261-8
15015004